SlideShare a Scribd company logo
Patient Safety – The Danish Experience
 Torben Mogensen, Medical Director
     Hvidovre Hospital, Denmark
Aim of the preliminary
             study
Calculation for full scale investigation
Test of method
Question:
The number of adverse events in Denmark =
number of adverse events in other countries ?

Estimation of the cost of adverse events
Estimation of the potential for prevention
Expected results of the
     preliminary investigation
                                    ÷
         +
                           Number of adverse
Number of adverse
                           events at each hospital
events in Denmark
                           or department
The price for adverse
                           Disability
events
                           Number of death
Potential for prevention
                           Which speciality
Test of method
                           Causation
Calculation for full
scale investigation        Identification of
                           patients with risk
                           Comparison of hospital
1.1
inp 07.6             Adverse Events Studies
   ati 32
      en
         ts
           England       Harvard   Australia   Utah/Colorado

            10,8 %
         Number of AEs   40.982
                         3,7 %     143.992
                                   13,0 %         32.121
                                                  2,9 %
AE’s        119.624

             66 % AEs
              Mild       56,8 %     46,6 %        53,3 %
Mild
           19 %
Modera. Moderate AEs     13,7 %     30,5 %        31,6 %
              6%
            Severe AEs    2,6 %     13,7 %         8,4 %
Severe
Deaths       8% Deaths   13,6 %
                          5.574     4,9 %
                                    7.056          6,6 %
                                                   2.120
             9.787
Index admission
               Index
             admission

Event     Found




                          Time
Definitions
                Adverse event


Not preventable Ae                 Preventable Ae
(complication)                             (error)



                     Technical error           Human error



                                  Latent failures            Active error


                                                                             Error of
                                               Error of action
                                                                            omission
Latent and active error
   -Human factor analyses




      Stanhope et al: Br J Obst and Gyne ,
           nov 97, 104, 1225 -1232
Investigators



• Experienced nurses
• Senior doctors
Education



• 2 day course
• Continuous evaluation
Method                           In-patients


                        Representative sample




                                                                       1. step
                              Nurse screening


                          Positive screening



         Medical evaluation                    Medical evaluation




                                                                       2. step
                        Comparison of answers


                        Possible adverse event




                                                                       3. step
     Senior medical evaluation             Senior medical evaluation

                                Conference
1.107.632
                                            In-patients
  Results
                                                                                 1.097
                                     Representative sample


      Record not useful              Nurse screening 1033


622                                                                                411
      Negative screening               Positive screening



                      Medical evaluation                   Medical evaluation

                                     Comparison of answers


      No adverse event                                                          Adverse event
                                     Possible adverse event


                                                64
                  Senior medical evaluation           Senior medical evaluation
282
                                            Conference


      No adverse event                                                          Adverse event
                                           No conclusion


              904                               15                                  114
Results
•   176 adverse events (complications & error)
•   114 admissions with adverse events
•   46 preventive adverse events (error)


•   Risk of adverse events and complications           5,3 % (54/1018)
•   Risk of adverse events due to error                2,1 %(22/1018)

•   Number of admissions with adverse events           9,0 %(92/1018)
•   Number of admissions with adverse events
    due to error                                       3,6 %(37/1018)

•   Increase in length of stay due to adverse events        7,0 days
Results – reduced ability to function
40
        39

30


                   25
20


                                        14
10                            12
                                                   9                   8
                                                             7
 0
     0-1 month   1-6 month 6-12 month Permanent Permanent   Death   Unknown
                                        1-50%    50-100%
Preliminary investigation of adverse events
                   2001
No adverse events 91%

                                     ”Error” 40%




                           Standard treatment 60%

       Adverse events 9%



                             www.dsi.dk/publikationer
1 .1
 pa 07.63                Adverse Events Studies
   tie
       nte 2
          r
                                                        Denmark
               Harvard      Australia   Utah/Colorado
                                                          1998
  Number
               3,7 %         13,0 %        2,9 %
               40.982       143.992        32.121       115.104
   of AEs


                             46,6 %        53,3 %
               56,8 %
  Mild AEs
 Moderate
                             30,5 %        31,6 %
               13,7 %
     AEs
                             13,7 %         8,4 %
                2,6 %
Severe AEs

                             4,9 %          6,6 %        7.067
               13,6 %
                5.574        7.056          2.120
   Deaths
Conclusions
• The total amount of adverse events in Denmark
  are comparable with previous studies from other
  countries.

             - Not better – not worse -

• The number of preventable adverse events are
  the same as in previous studies.

• The investigation too small to evaluate the
  number of death due to adverse events.
The Magic 3 Years
                                 Danish Society for
                                 Patient Safety

                                                             Law on Patient
                            Danish A.E.
                                                             Safety
                            Study
                            published

                      H:S Unit of
                                                  Study with
                      Patient Safety
                                                  Recommendations
   What is Patient
   Safety?




2000                 2001                  2002                2003
Teamwork
Danish Society for Patient Safety
• Established December, 2001
• Stakeholders represented in the board by their
  president (hospital owners, professions, industry,
  research & patient organisations)
• Gathers, spreads and develops knowledge and
  initiatives
• Has become an important political factor
Law on Patient Safety
Law on Patient Safety
passed in the




                                              ion
Parliament June 2003




                                           sat
                               Learning
                         t
                        lain



                                         en
                                       mp
                      mp




                                     Co
                    Co
Law on Patient Safety,
           June 2003
Frontline Personnel obligated to report
Hospital Owners are obligated to act
Board of Health are obligated to
 communicate
§6 in Law on
           Patient Safety
A health care professional reporting an
adverse event shall not as a result of such
reporting be subjected to disciplinary
investigations or measures by the
Employing Authority, Supervisory
Reactions by the National Board of Health
or Criminal Sanctions by the Courts.
The hard work is yet to come
What can you expect in Spain?
54.
      835
            . 76
                   0 in                   Adverse Events Studies
                          pat
                             i en
                                    ts*

                          England         Harvard     Australia     Utah/Colorado

                      10,8 %
                   Number of AEs          2.028.904
                                            3,7 %     7.128.641
                                                       13,0 %          1.590.221
                                                                         2,9 %
                     5.922.262
AE’s

                             66 % AEs
                              Mild         56,8 %      46,6 %           53,3 %
Mild
           19 %
Modera. Moderate AEs                       13,7 %      30,5 %           31,6 %
                            6%
                          Severe AEs       2,6 %       13,7 %            8,4 %
Severe
Deaths                       8%Deaths     275.953
                                          13,6 %      349.323
                                                       4,9 %            104.955
                                                                         6,6 %
                            473.781

*) excl. Greece and UK. Numbers are from 2000, except Germany where the number is from
1999, OECD Health Data 2003, 3rd ed.
4 .5
        02.
              740
                                          Adverse Events Studies
                    i np
                           atie
                                n   ts*

                      England             Harvard   Australia   Utah/Colorado

                  10,8 %                  166.601
               Number of AEs               3,7 %    13,0 %          2,9 %
                  486.296                           585.356        130.579
AE’s

                           66 % AEs
                            Mild           56,8 %    46,6 %        53,3 %
Mild
           19 %
Modera. Moderate AEs                       13,7 %    30,5 %        31,6 %
                        6%
                      Severe AEs           2,6 %     13,7 %         8,4 %
Severe
Deaths                                    22.658
                        8%
                       38.904
                           Deaths          13,6 %    4,9 %          6,6 %
                                                     28.682         8.618

*) Number is from 2000, OECD Health Data 2003, 3rd ed.

More Related Content

What's hot

Trials on trial: equivalence, ethics and evidence
Trials on trial: equivalence, ethics and evidenceTrials on trial: equivalence, ethics and evidence
Trials on trial: equivalence, ethics and evidence
Cochrane.Collaboration
 
Bill miller icmi 2012 plenary
Bill miller icmi 2012 plenaryBill miller icmi 2012 plenary
Bill miller icmi 2012 plenary
Magnus Johansson
 
Ten Most Common Mistakes in Clinical Trial Interpretation
Ten Most Common Mistakes in Clinical Trial InterpretationTen Most Common Mistakes in Clinical Trial Interpretation
Ten Most Common Mistakes in Clinical Trial Interpretation
clinicaltrialist
 
Ten Most Common Mistakes in Clinical Trial Interpretation - Slidecast
Ten Most Common Mistakes in Clinical Trial Interpretation - SlidecastTen Most Common Mistakes in Clinical Trial Interpretation - Slidecast
Ten Most Common Mistakes in Clinical Trial Interpretation - Slidecast
clinicaltrialist
 
Bayesian clinical test
Bayesian clinical testBayesian clinical test
Bayesian clinical test
Gaetan Lion
 
Comparing Treatment Results Of PROSTATE CANCER
Comparing Treatment Results Of PROSTATE CANCERComparing Treatment Results Of PROSTATE CANCER
Comparing Treatment Results Of PROSTATE CANCER
Prostate Seed Institute in Texas
 
Aderenta si riscul cardiovascul
Aderenta si riscul cardiovasculAderenta si riscul cardiovascul
Aderenta si riscul cardiovascul
ALEXANDRU ANDRITOIU
 
2012 11-7 pcqn data quality session
2012 11-7 pcqn data quality session2012 11-7 pcqn data quality session
2012 11-7 pcqn data quality session
rubyclare
 
Disease & Conditions Findability Highlights | Web Committee Children's Hospital
Disease & Conditions Findability Highlights | Web Committee Children's HospitalDisease & Conditions Findability Highlights | Web Committee Children's Hospital
Disease & Conditions Findability Highlights | Web Committee Children's Hospital
Kaitlan Chu
 
Pep and prep smith
Pep and prep smithPep and prep smith
Pep and prep smith
healthhiv
 
Reducing Costs Using Shared Decision Making
Reducing Costs Using Shared Decision MakingReducing Costs Using Shared Decision Making
Reducing Costs Using Shared Decision Making
Informed Medical Decisions Foundation
 
ACE: The First Experience with Angiographic Reviews
ACE: The First Experience with Angiographic ReviewsACE: The First Experience with Angiographic Reviews
ACE: The First Experience with Angiographic Reviews
bnolke
 
Dermatology Times May 2015 ezine
Dermatology Times May 2015 ezineDermatology Times May 2015 ezine
Dermatology Times May 2015 ezine
Pamela Kreigh
 
Pan Pacific Clinical Practice Guideline For The Prevention And Management Of ...
Pan Pacific Clinical Practice Guideline For The Prevention And Management Of ...Pan Pacific Clinical Practice Guideline For The Prevention And Management Of ...
Pan Pacific Clinical Practice Guideline For The Prevention And Management Of ...
GNEAUPP.
 
Comparisonof Clinical Diagnoses versus Computerized Test Diagnoses Using the ...
Comparisonof Clinical Diagnoses versus Computerized Test Diagnoses Using the ...Comparisonof Clinical Diagnoses versus Computerized Test Diagnoses Using the ...
Comparisonof Clinical Diagnoses versus Computerized Test Diagnoses Using the ...
Nelson Hendler
 
PCPs speak out on rad reporting
PCPs speak out on rad reportingPCPs speak out on rad reporting
PCPs speak out on rad reporting
TriMed Media Group
 
Dose selection nyu 012815 2
Dose selection nyu 012815 2Dose selection nyu 012815 2
Dose selection nyu 012815 2
jssilverman00
 
Bariatric surgery and copra ossicon 2016 presentation
Bariatric surgery and copra ossicon 2016 presentationBariatric surgery and copra ossicon 2016 presentation
Bariatric surgery and copra ossicon 2016 presentation
Abhishek Katakwar
 
Evidence-Based Medicine Glossary
Evidence-Based Medicine GlossaryEvidence-Based Medicine Glossary
Evidence-Based Medicine Glossary
Dr. Faisal Al Haddad
 

What's hot (19)

Trials on trial: equivalence, ethics and evidence
Trials on trial: equivalence, ethics and evidenceTrials on trial: equivalence, ethics and evidence
Trials on trial: equivalence, ethics and evidence
 
Bill miller icmi 2012 plenary
Bill miller icmi 2012 plenaryBill miller icmi 2012 plenary
Bill miller icmi 2012 plenary
 
Ten Most Common Mistakes in Clinical Trial Interpretation
Ten Most Common Mistakes in Clinical Trial InterpretationTen Most Common Mistakes in Clinical Trial Interpretation
Ten Most Common Mistakes in Clinical Trial Interpretation
 
Ten Most Common Mistakes in Clinical Trial Interpretation - Slidecast
Ten Most Common Mistakes in Clinical Trial Interpretation - SlidecastTen Most Common Mistakes in Clinical Trial Interpretation - Slidecast
Ten Most Common Mistakes in Clinical Trial Interpretation - Slidecast
 
Bayesian clinical test
Bayesian clinical testBayesian clinical test
Bayesian clinical test
 
Comparing Treatment Results Of PROSTATE CANCER
Comparing Treatment Results Of PROSTATE CANCERComparing Treatment Results Of PROSTATE CANCER
Comparing Treatment Results Of PROSTATE CANCER
 
Aderenta si riscul cardiovascul
Aderenta si riscul cardiovasculAderenta si riscul cardiovascul
Aderenta si riscul cardiovascul
 
2012 11-7 pcqn data quality session
2012 11-7 pcqn data quality session2012 11-7 pcqn data quality session
2012 11-7 pcqn data quality session
 
Disease & Conditions Findability Highlights | Web Committee Children's Hospital
Disease & Conditions Findability Highlights | Web Committee Children's HospitalDisease & Conditions Findability Highlights | Web Committee Children's Hospital
Disease & Conditions Findability Highlights | Web Committee Children's Hospital
 
Pep and prep smith
Pep and prep smithPep and prep smith
Pep and prep smith
 
Reducing Costs Using Shared Decision Making
Reducing Costs Using Shared Decision MakingReducing Costs Using Shared Decision Making
Reducing Costs Using Shared Decision Making
 
ACE: The First Experience with Angiographic Reviews
ACE: The First Experience with Angiographic ReviewsACE: The First Experience with Angiographic Reviews
ACE: The First Experience with Angiographic Reviews
 
Dermatology Times May 2015 ezine
Dermatology Times May 2015 ezineDermatology Times May 2015 ezine
Dermatology Times May 2015 ezine
 
Pan Pacific Clinical Practice Guideline For The Prevention And Management Of ...
Pan Pacific Clinical Practice Guideline For The Prevention And Management Of ...Pan Pacific Clinical Practice Guideline For The Prevention And Management Of ...
Pan Pacific Clinical Practice Guideline For The Prevention And Management Of ...
 
Comparisonof Clinical Diagnoses versus Computerized Test Diagnoses Using the ...
Comparisonof Clinical Diagnoses versus Computerized Test Diagnoses Using the ...Comparisonof Clinical Diagnoses versus Computerized Test Diagnoses Using the ...
Comparisonof Clinical Diagnoses versus Computerized Test Diagnoses Using the ...
 
PCPs speak out on rad reporting
PCPs speak out on rad reportingPCPs speak out on rad reporting
PCPs speak out on rad reporting
 
Dose selection nyu 012815 2
Dose selection nyu 012815 2Dose selection nyu 012815 2
Dose selection nyu 012815 2
 
Bariatric surgery and copra ossicon 2016 presentation
Bariatric surgery and copra ossicon 2016 presentationBariatric surgery and copra ossicon 2016 presentation
Bariatric surgery and copra ossicon 2016 presentation
 
Evidence-Based Medicine Glossary
Evidence-Based Medicine GlossaryEvidence-Based Medicine Glossary
Evidence-Based Medicine Glossary
 

Viewers also liked

Eliminate devastating medical errors with 10 high reliability safety tools
Eliminate devastating medical errors with 10 high reliability safety toolsEliminate devastating medical errors with 10 high reliability safety tools
Eliminate devastating medical errors with 10 high reliability safety tools
John Byrnes, MD
 
Patient Satisfaction, Patient Reported Outcomes, Safety, and Quality of Care
Patient Satisfaction, Patient Reported Outcomes, Safety, and Quality of CarePatient Satisfaction, Patient Reported Outcomes, Safety, and Quality of Care
Patient Satisfaction, Patient Reported Outcomes, Safety, and Quality of Care
Yana Puckett, MD, MPH, MS
 
CU Errors, clinical governance and patient safety
CU Errors, clinical governance and patient safetyCU Errors, clinical governance and patient safety
CU Errors, clinical governance and patient safety
Medic-ELearning
 
62571
6257162571
Reducing Medical Error and increasing patient safety Reducing Medical Error...
Reducing Medical Error and increasing patient safety 	 Reducing Medical Error...Reducing Medical Error and increasing patient safety 	 Reducing Medical Error...
Reducing Medical Error and increasing patient safety Reducing Medical Error...
MedicineAndHealth
 
Medical errors
Medical errorsMedical errors
Medical errors
Imran Javed
 
Evolution and transformation of patient safety in to the modern health care s...
Evolution and transformation of patient safety in to the modern health care s...Evolution and transformation of patient safety in to the modern health care s...
Evolution and transformation of patient safety in to the modern health care s...
Krishnan Sankara Narayanan MS, MBA, CPHQ, FASHRM, LHRM
 
Patient safety
Patient safetyPatient safety
Patient safety
Nc Das
 

Viewers also liked (8)

Eliminate devastating medical errors with 10 high reliability safety tools
Eliminate devastating medical errors with 10 high reliability safety toolsEliminate devastating medical errors with 10 high reliability safety tools
Eliminate devastating medical errors with 10 high reliability safety tools
 
Patient Satisfaction, Patient Reported Outcomes, Safety, and Quality of Care
Patient Satisfaction, Patient Reported Outcomes, Safety, and Quality of CarePatient Satisfaction, Patient Reported Outcomes, Safety, and Quality of Care
Patient Satisfaction, Patient Reported Outcomes, Safety, and Quality of Care
 
CU Errors, clinical governance and patient safety
CU Errors, clinical governance and patient safetyCU Errors, clinical governance and patient safety
CU Errors, clinical governance and patient safety
 
62571
6257162571
62571
 
Reducing Medical Error and increasing patient safety Reducing Medical Error...
Reducing Medical Error and increasing patient safety 	 Reducing Medical Error...Reducing Medical Error and increasing patient safety 	 Reducing Medical Error...
Reducing Medical Error and increasing patient safety Reducing Medical Error...
 
Medical errors
Medical errorsMedical errors
Medical errors
 
Evolution and transformation of patient safety in to the modern health care s...
Evolution and transformation of patient safety in to the modern health care s...Evolution and transformation of patient safety in to the modern health care s...
Evolution and transformation of patient safety in to the modern health care s...
 
Patient safety
Patient safetyPatient safety
Patient safety
 

Similar to Patient Safety – The Danish Experience

Sof stat issues_pro
Sof stat issues_proSof stat issues_pro
Sof stat issues_pro
Jonas Ranstam PhD
 
Parallel Session 4.6 Developing Your Team’s Safety Culture and Safety Practic...
Parallel Session 4.6 Developing Your Team’s Safety Culture and Safety Practic...Parallel Session 4.6 Developing Your Team’s Safety Culture and Safety Practic...
Parallel Session 4.6 Developing Your Team’s Safety Culture and Safety Practic...
NHSScotlandEvent
 
Fo gm vi-cinnamonbloss_idiom_7march2013_fina_lpost
Fo gm vi-cinnamonbloss_idiom_7march2013_fina_lpostFo gm vi-cinnamonbloss_idiom_7march2013_fina_lpost
Fo gm vi-cinnamonbloss_idiom_7march2013_fina_lpost
CinnamonBloss
 
Risk Management and Patient Safety Evolution and Progress
Risk Management and Patient Safety Evolution and ProgressRisk Management and Patient Safety Evolution and Progress
Risk Management and Patient Safety Evolution and Progress
Plan de Calidad para el SNS
 
Apply Patient Safety Solutions to Clinical Practice: why is it so hard by S. ...
Apply Patient Safety Solutions to Clinical Practice: why is it so hard by S. ...Apply Patient Safety Solutions to Clinical Practice: why is it so hard by S. ...
Apply Patient Safety Solutions to Clinical Practice: why is it so hard by S. ...
ALIAS Network
 
Medical errors, negligence, and litigation
Medical errors, negligence, and litigationMedical errors, negligence, and litigation
Medical errors, negligence, and litigation
MedicineAndHealth
 
Stoppen Met Antidepressiva
Stoppen Met AntidepressivaStoppen Met Antidepressiva
Stoppen Met Antidepressiva
RobHeerdink
 
UAB Pulmonary board review study design and statistical principles
UAB Pulmonary board review study  design and statistical principles UAB Pulmonary board review study  design and statistical principles
UAB Pulmonary board review study design and statistical principles
Terry Shaneyfelt
 
Samir Sinha: Canadian innovation in caring for older adults
Samir Sinha: Canadian innovation in caring for older adultsSamir Sinha: Canadian innovation in caring for older adults
Samir Sinha: Canadian innovation in caring for older adults
Nuffield Trust
 
Evidence in Digital Healthcare
Evidence in Digital HealthcareEvidence in Digital Healthcare
Evidence in Digital Healthcare
Idh Warwick
 
Evidence in Digital Healthcare
Evidence in Digital HealthcareEvidence in Digital Healthcare
Evidence in Digital Healthcare
Idh Warwick
 
Screening and diagnostic testing
Screening and diagnostic  testingScreening and diagnostic  testing
Screening and diagnostic testing
amitakashyap1
 
MCC 2011 - Slide 5
MCC 2011 - Slide 5MCC 2011 - Slide 5
MCC 2011 - Slide 5
European School of Oncology
 
Efficacy and safety of microvascular decompression for trigeminal in patients...
Efficacy and safety of microvascular decompression for trigeminal in patients...Efficacy and safety of microvascular decompression for trigeminal in patients...
Efficacy and safety of microvascular decompression for trigeminal in patients...
neurologia segura
 
HM 2012 session-VIII patient safety
HM 2012 session-VIII patient safetyHM 2012 session-VIII patient safety
HM 2012 session-VIII patient safety
drbhutto
 
Screening for disease (ravi)
Screening for disease (ravi)Screening for disease (ravi)
Screening for disease (ravi)
Ravikant
 
Current Scenario in Male Infertility for IVF Specialists
Current Scenario in Male Infertility for IVF SpecialistsCurrent Scenario in Male Infertility for IVF Specialists
Current Scenario in Male Infertility for IVF Specialists
Sandro Esteves
 
IV Jornada. Sp y práctica reflexiva f borrell_pompeu fabra_2011
IV Jornada. Sp y práctica reflexiva f borrell_pompeu fabra_2011IV Jornada. Sp y práctica reflexiva f borrell_pompeu fabra_2011
IV Jornada. Sp y práctica reflexiva f borrell_pompeu fabra_2011
Sano y Salvo
 
Cc cohort1
Cc cohort1Cc cohort1
Cc cohort1
drasifk
 
UOG Journal Club: Twin–twin transfusion syndrome: a frequently missed diagnos...
UOG Journal Club: Twin–twin transfusion syndrome: a frequently missed diagnos...UOG Journal Club: Twin–twin transfusion syndrome: a frequently missed diagnos...
UOG Journal Club: Twin–twin transfusion syndrome: a frequently missed diagnos...
International Society of Ultrasound in Obstetrics and Gynecology (ISUOG)
 

Similar to Patient Safety – The Danish Experience (20)

Sof stat issues_pro
Sof stat issues_proSof stat issues_pro
Sof stat issues_pro
 
Parallel Session 4.6 Developing Your Team’s Safety Culture and Safety Practic...
Parallel Session 4.6 Developing Your Team’s Safety Culture and Safety Practic...Parallel Session 4.6 Developing Your Team’s Safety Culture and Safety Practic...
Parallel Session 4.6 Developing Your Team’s Safety Culture and Safety Practic...
 
Fo gm vi-cinnamonbloss_idiom_7march2013_fina_lpost
Fo gm vi-cinnamonbloss_idiom_7march2013_fina_lpostFo gm vi-cinnamonbloss_idiom_7march2013_fina_lpost
Fo gm vi-cinnamonbloss_idiom_7march2013_fina_lpost
 
Risk Management and Patient Safety Evolution and Progress
Risk Management and Patient Safety Evolution and ProgressRisk Management and Patient Safety Evolution and Progress
Risk Management and Patient Safety Evolution and Progress
 
Apply Patient Safety Solutions to Clinical Practice: why is it so hard by S. ...
Apply Patient Safety Solutions to Clinical Practice: why is it so hard by S. ...Apply Patient Safety Solutions to Clinical Practice: why is it so hard by S. ...
Apply Patient Safety Solutions to Clinical Practice: why is it so hard by S. ...
 
Medical errors, negligence, and litigation
Medical errors, negligence, and litigationMedical errors, negligence, and litigation
Medical errors, negligence, and litigation
 
Stoppen Met Antidepressiva
Stoppen Met AntidepressivaStoppen Met Antidepressiva
Stoppen Met Antidepressiva
 
UAB Pulmonary board review study design and statistical principles
UAB Pulmonary board review study  design and statistical principles UAB Pulmonary board review study  design and statistical principles
UAB Pulmonary board review study design and statistical principles
 
Samir Sinha: Canadian innovation in caring for older adults
Samir Sinha: Canadian innovation in caring for older adultsSamir Sinha: Canadian innovation in caring for older adults
Samir Sinha: Canadian innovation in caring for older adults
 
Evidence in Digital Healthcare
Evidence in Digital HealthcareEvidence in Digital Healthcare
Evidence in Digital Healthcare
 
Evidence in Digital Healthcare
Evidence in Digital HealthcareEvidence in Digital Healthcare
Evidence in Digital Healthcare
 
Screening and diagnostic testing
Screening and diagnostic  testingScreening and diagnostic  testing
Screening and diagnostic testing
 
MCC 2011 - Slide 5
MCC 2011 - Slide 5MCC 2011 - Slide 5
MCC 2011 - Slide 5
 
Efficacy and safety of microvascular decompression for trigeminal in patients...
Efficacy and safety of microvascular decompression for trigeminal in patients...Efficacy and safety of microvascular decompression for trigeminal in patients...
Efficacy and safety of microvascular decompression for trigeminal in patients...
 
HM 2012 session-VIII patient safety
HM 2012 session-VIII patient safetyHM 2012 session-VIII patient safety
HM 2012 session-VIII patient safety
 
Screening for disease (ravi)
Screening for disease (ravi)Screening for disease (ravi)
Screening for disease (ravi)
 
Current Scenario in Male Infertility for IVF Specialists
Current Scenario in Male Infertility for IVF SpecialistsCurrent Scenario in Male Infertility for IVF Specialists
Current Scenario in Male Infertility for IVF Specialists
 
IV Jornada. Sp y práctica reflexiva f borrell_pompeu fabra_2011
IV Jornada. Sp y práctica reflexiva f borrell_pompeu fabra_2011IV Jornada. Sp y práctica reflexiva f borrell_pompeu fabra_2011
IV Jornada. Sp y práctica reflexiva f borrell_pompeu fabra_2011
 
Cc cohort1
Cc cohort1Cc cohort1
Cc cohort1
 
UOG Journal Club: Twin–twin transfusion syndrome: a frequently missed diagnos...
UOG Journal Club: Twin–twin transfusion syndrome: a frequently missed diagnos...UOG Journal Club: Twin–twin transfusion syndrome: a frequently missed diagnos...
UOG Journal Club: Twin–twin transfusion syndrome: a frequently missed diagnos...
 

More from Plan de Calidad para el SNS

Multidisciplinary care: a perspective from diagnosis and treatment of rare ca...
Multidisciplinary care: a perspective from diagnosis and treatment of rare ca...Multidisciplinary care: a perspective from diagnosis and treatment of rare ca...
Multidisciplinary care: a perspective from diagnosis and treatment of rare ca...
Plan de Calidad para el SNS
 
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
Plan de Calidad para el SNS
 
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
Plan de Calidad para el SNS
 
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
Plan de Calidad para el SNS
 
Experiencias y percepción de la atención integral de los pacientes con cáncer
Experiencias y percepción de la atención integral de los pacientes con cáncerExperiencias y percepción de la atención integral de los pacientes con cáncer
Experiencias y percepción de la atención integral de los pacientes con cáncer
Plan de Calidad para el SNS
 
Experiencias y percepción de la atención integral de los pacientes con cáncer
Experiencias y percepción de la atención integral de los pacientes con cáncerExperiencias y percepción de la atención integral de los pacientes con cáncer
Experiencias y percepción de la atención integral de los pacientes con cáncer
Plan de Calidad para el SNS
 
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
Plan de Calidad para el SNS
 
Experiencias y percepción de la atención integral de los pacientes con cáncer
Experiencias y percepción de la atención integral de los pacientes con cáncerExperiencias y percepción de la atención integral de los pacientes con cáncer
Experiencias y percepción de la atención integral de los pacientes con cáncer
Plan de Calidad para el SNS
 
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
Plan de Calidad para el SNS
 
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
Plan de Calidad para el SNS
 
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
Plan de Calidad para el SNS
 
The power of lifestyle interventions to prevent cardiovascular diseases
The power of lifestyle interventions to prevent cardiovascular diseasesThe power of lifestyle interventions to prevent cardiovascular diseases
The power of lifestyle interventions to prevent cardiovascular diseases
Plan de Calidad para el SNS
 
Alcohol and chronic diseases: complex relations
Alcohol and chronic diseases: complex relationsAlcohol and chronic diseases: complex relations
Alcohol and chronic diseases: complex relations
Plan de Calidad para el SNS
 
Risk Assessment and Management of Cardiovascular Diseases - an English Approach
Risk Assessment and Management of Cardiovascular Diseases - an English ApproachRisk Assessment and Management of Cardiovascular Diseases - an English Approach
Risk Assessment and Management of Cardiovascular Diseases - an English Approach
Plan de Calidad para el SNS
 
Cardiovascular disease inequalities: causes and consequences
Cardiovascular disease inequalities: causes and consequencesCardiovascular disease inequalities: causes and consequences
Cardiovascular disease inequalities: causes and consequences
Plan de Calidad para el SNS
 
Anti-Smoking policies in Ireland
Anti-Smoking policies in IrelandAnti-Smoking policies in Ireland
Anti-Smoking policies in Ireland
Plan de Calidad para el SNS
 
Addressing cardiovascular disease at EU level: tangible plans for the future
Addressing cardiovascular disease at EU level: tangible plans for the futureAddressing cardiovascular disease at EU level: tangible plans for the future
Addressing cardiovascular disease at EU level: tangible plans for the future
Plan de Calidad para el SNS
 
eHealth Reality in North America
eHealth Reality in North AmericaeHealth Reality in North America
eHealth Reality in North America
Plan de Calidad para el SNS
 
B2B Medical Intermediaries
B2B Medical IntermediariesB2B Medical Intermediaries
B2B Medical Intermediaries
Plan de Calidad para el SNS
 
The impact of eHealth on Healthcare Professionals and Organisations: The Impa...
The impact of eHealth on Healthcare Professionals and Organisations: The Impa...The impact of eHealth on Healthcare Professionals and Organisations: The Impa...
The impact of eHealth on Healthcare Professionals and Organisations: The Impa...
Plan de Calidad para el SNS
 

More from Plan de Calidad para el SNS (20)

Multidisciplinary care: a perspective from diagnosis and treatment of rare ca...
Multidisciplinary care: a perspective from diagnosis and treatment of rare ca...Multidisciplinary care: a perspective from diagnosis and treatment of rare ca...
Multidisciplinary care: a perspective from diagnosis and treatment of rare ca...
 
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
 
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
 
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
 
Experiencias y percepción de la atención integral de los pacientes con cáncer
Experiencias y percepción de la atención integral de los pacientes con cáncerExperiencias y percepción de la atención integral de los pacientes con cáncer
Experiencias y percepción de la atención integral de los pacientes con cáncer
 
Experiencias y percepción de la atención integral de los pacientes con cáncer
Experiencias y percepción de la atención integral de los pacientes con cáncerExperiencias y percepción de la atención integral de los pacientes con cáncer
Experiencias y percepción de la atención integral de los pacientes con cáncer
 
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
 
Experiencias y percepción de la atención integral de los pacientes con cáncer
Experiencias y percepción de la atención integral de los pacientes con cáncerExperiencias y percepción de la atención integral de los pacientes con cáncer
Experiencias y percepción de la atención integral de los pacientes con cáncer
 
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
 
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
 
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
 
The power of lifestyle interventions to prevent cardiovascular diseases
The power of lifestyle interventions to prevent cardiovascular diseasesThe power of lifestyle interventions to prevent cardiovascular diseases
The power of lifestyle interventions to prevent cardiovascular diseases
 
Alcohol and chronic diseases: complex relations
Alcohol and chronic diseases: complex relationsAlcohol and chronic diseases: complex relations
Alcohol and chronic diseases: complex relations
 
Risk Assessment and Management of Cardiovascular Diseases - an English Approach
Risk Assessment and Management of Cardiovascular Diseases - an English ApproachRisk Assessment and Management of Cardiovascular Diseases - an English Approach
Risk Assessment and Management of Cardiovascular Diseases - an English Approach
 
Cardiovascular disease inequalities: causes and consequences
Cardiovascular disease inequalities: causes and consequencesCardiovascular disease inequalities: causes and consequences
Cardiovascular disease inequalities: causes and consequences
 
Anti-Smoking policies in Ireland
Anti-Smoking policies in IrelandAnti-Smoking policies in Ireland
Anti-Smoking policies in Ireland
 
Addressing cardiovascular disease at EU level: tangible plans for the future
Addressing cardiovascular disease at EU level: tangible plans for the futureAddressing cardiovascular disease at EU level: tangible plans for the future
Addressing cardiovascular disease at EU level: tangible plans for the future
 
eHealth Reality in North America
eHealth Reality in North AmericaeHealth Reality in North America
eHealth Reality in North America
 
B2B Medical Intermediaries
B2B Medical IntermediariesB2B Medical Intermediaries
B2B Medical Intermediaries
 
The impact of eHealth on Healthcare Professionals and Organisations: The Impa...
The impact of eHealth on Healthcare Professionals and Organisations: The Impa...The impact of eHealth on Healthcare Professionals and Organisations: The Impa...
The impact of eHealth on Healthcare Professionals and Organisations: The Impa...
 

Recently uploaded

CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Ayurveda ForAll
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
19various
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
Outbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptxOutbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptx
Pratik328635
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Jim Jacob Roy
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 

Recently uploaded (20)

CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
Outbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptxOutbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 

Patient Safety – The Danish Experience

  • 1. Patient Safety – The Danish Experience Torben Mogensen, Medical Director Hvidovre Hospital, Denmark
  • 2.
  • 3. Aim of the preliminary study Calculation for full scale investigation Test of method Question: The number of adverse events in Denmark = number of adverse events in other countries ? Estimation of the cost of adverse events Estimation of the potential for prevention
  • 4. Expected results of the preliminary investigation ÷ + Number of adverse Number of adverse events at each hospital events in Denmark or department The price for adverse Disability events Number of death Potential for prevention Which speciality Test of method Causation Calculation for full scale investigation Identification of patients with risk Comparison of hospital
  • 5. 1.1 inp 07.6 Adverse Events Studies ati 32 en ts England Harvard Australia Utah/Colorado 10,8 % Number of AEs 40.982 3,7 % 143.992 13,0 % 32.121 2,9 % AE’s 119.624 66 % AEs Mild 56,8 % 46,6 % 53,3 % Mild 19 % Modera. Moderate AEs 13,7 % 30,5 % 31,6 % 6% Severe AEs 2,6 % 13,7 % 8,4 % Severe Deaths 8% Deaths 13,6 % 5.574 4,9 % 7.056 6,6 % 2.120 9.787
  • 6. Index admission Index admission Event Found Time
  • 7. Definitions Adverse event Not preventable Ae Preventable Ae (complication) (error) Technical error Human error Latent failures Active error Error of Error of action omission
  • 8. Latent and active error -Human factor analyses Stanhope et al: Br J Obst and Gyne , nov 97, 104, 1225 -1232
  • 10. Education • 2 day course • Continuous evaluation
  • 11. Method In-patients Representative sample 1. step Nurse screening Positive screening Medical evaluation Medical evaluation 2. step Comparison of answers Possible adverse event 3. step Senior medical evaluation Senior medical evaluation Conference
  • 12. 1.107.632 In-patients Results 1.097 Representative sample Record not useful Nurse screening 1033 622 411 Negative screening Positive screening Medical evaluation Medical evaluation Comparison of answers No adverse event Adverse event Possible adverse event 64 Senior medical evaluation Senior medical evaluation 282 Conference No adverse event Adverse event No conclusion 904 15 114
  • 13. Results • 176 adverse events (complications & error) • 114 admissions with adverse events • 46 preventive adverse events (error) • Risk of adverse events and complications 5,3 % (54/1018) • Risk of adverse events due to error 2,1 %(22/1018) • Number of admissions with adverse events 9,0 %(92/1018) • Number of admissions with adverse events due to error 3,6 %(37/1018) • Increase in length of stay due to adverse events 7,0 days
  • 14. Results – reduced ability to function 40 39 30 25 20 14 10 12 9 8 7 0 0-1 month 1-6 month 6-12 month Permanent Permanent Death Unknown 1-50% 50-100%
  • 15. Preliminary investigation of adverse events 2001 No adverse events 91% ”Error” 40% Standard treatment 60% Adverse events 9% www.dsi.dk/publikationer
  • 16. 1 .1 pa 07.63 Adverse Events Studies tie nte 2 r Denmark Harvard Australia Utah/Colorado 1998 Number 3,7 % 13,0 % 2,9 % 40.982 143.992 32.121 115.104 of AEs 46,6 % 53,3 % 56,8 % Mild AEs Moderate 30,5 % 31,6 % 13,7 % AEs 13,7 % 8,4 % 2,6 % Severe AEs 4,9 % 6,6 % 7.067 13,6 % 5.574 7.056 2.120 Deaths
  • 17. Conclusions • The total amount of adverse events in Denmark are comparable with previous studies from other countries. - Not better – not worse - • The number of preventable adverse events are the same as in previous studies. • The investigation too small to evaluate the number of death due to adverse events.
  • 18. The Magic 3 Years Danish Society for Patient Safety Law on Patient Danish A.E. Safety Study published H:S Unit of Study with Patient Safety Recommendations What is Patient Safety? 2000 2001 2002 2003
  • 19. Teamwork Danish Society for Patient Safety • Established December, 2001 • Stakeholders represented in the board by their president (hospital owners, professions, industry, research & patient organisations) • Gathers, spreads and develops knowledge and initiatives • Has become an important political factor
  • 20. Law on Patient Safety Law on Patient Safety passed in the ion Parliament June 2003 sat Learning t lain en mp mp Co Co
  • 21. Law on Patient Safety, June 2003 Frontline Personnel obligated to report Hospital Owners are obligated to act Board of Health are obligated to communicate
  • 22. §6 in Law on Patient Safety A health care professional reporting an adverse event shall not as a result of such reporting be subjected to disciplinary investigations or measures by the Employing Authority, Supervisory Reactions by the National Board of Health or Criminal Sanctions by the Courts.
  • 23. The hard work is yet to come
  • 24. What can you expect in Spain?
  • 25. 54. 835 . 76 0 in Adverse Events Studies pat i en ts* England Harvard Australia Utah/Colorado 10,8 % Number of AEs 2.028.904 3,7 % 7.128.641 13,0 % 1.590.221 2,9 % 5.922.262 AE’s 66 % AEs Mild 56,8 % 46,6 % 53,3 % Mild 19 % Modera. Moderate AEs 13,7 % 30,5 % 31,6 % 6% Severe AEs 2,6 % 13,7 % 8,4 % Severe Deaths 8%Deaths 275.953 13,6 % 349.323 4,9 % 104.955 6,6 % 473.781 *) excl. Greece and UK. Numbers are from 2000, except Germany where the number is from 1999, OECD Health Data 2003, 3rd ed.
  • 26. 4 .5 02. 740 Adverse Events Studies i np atie n ts* England Harvard Australia Utah/Colorado 10,8 % 166.601 Number of AEs 3,7 % 13,0 % 2,9 % 486.296 585.356 130.579 AE’s 66 % AEs Mild 56,8 % 46,6 % 53,3 % Mild 19 % Modera. Moderate AEs 13,7 % 30,5 % 31,6 % 6% Severe AEs 2,6 % 13,7 % 8,4 % Severe Deaths 22.658 8% 38.904 Deaths 13,6 % 4,9 % 6,6 % 28.682 8.618 *) Number is from 2000, OECD Health Data 2003, 3rd ed.